Every product deserves a verified identity.
Counterfeiting undermines safety, commerce, and trust. BONAFYD introduces a living authentication layer designed to make counterfeit activity detectable—and economically unsustainable.
A counterfeit only needs one opening in the chain.
The same handful of entry vectors reappear whether the product is a vial of insulin, a handbag, a brake pad, or a bottle of wine.
Counterfeiting operates at global scale.
Figures come from OECD/EUIPO, the WHO, the U.S. CDC and manufacturer disclosures, and each is attributed to its source.
Third-party estimates, shown for scale. Check the cited source for current figures.
Not just lost revenue. Counterfeits cost far more.
Physical harm
Substandard medicines and unsafe parts put lives at risk.
Lost value
Lost sales, displaced jobs and lost tax revenue.
Lost trust
Damaged brands, criminal networks and diverted resources.
Not just a serial number. A living digital twin.
Every protected product gets a live digital twin: a record of what it is, where it has been, and whether it is authentic. One framework runs across sectors.
The system is additive. It sits on top of the track-and-trace or serialization infrastructure already in place in each sector — no infrastructure replacement.
Unique identity
GS1 identifiers, with NFC or RFID where product value justifies it.
Product authenticity
Data describes a product. BONAFYD proves this unit is the one described.
Enforced lifecycle
A missed scan is flagged as a potential fake at the next gate.
Economic deterrence
Cloning stops paying. Duplicates are flagged when scanned. Scale brings risk, not profit.
Selective visual check
Image comparison only where contents can differ from packaging.
Data privacy
Product data stays with the manufacturer. The ledger holds only state and the digital twin's fingerprint.
Connected intelligence
Online monitoring and the physical chain strengthen each other.
Introducing MedAuth. Pharmacy first, where trust matters most.
MedAuth adds product-level authentication to existing DSCSA and EPCIS workflows across physical and online pharmacy channels, with no infrastructure replacement.
Built for real-world validation
- Connect to existing EPCIS events
- Run pharmacy and consumer verification
- Detect duplicate and out-of-sequence scans
- Link the licensed chain with online marketplaces
- Measure alert speed and false positives, then decide on expansion
Running today as a working proof of concept.
Make authenticity a competitive advantage.
Explore how a BONAFYD pilot could help protect products, customers, and confidence across your supply chain.
Discuss a Pilot →